KERALA AYURVEDA
Back to Balance Sheet
|
KERALA AYURVEDA Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹124 Cr | ₹141 Cr | ₹115 Cr | ₹110 Cr | ₹114 Cr |
What is the latest Total Liabilities ratio of KERALA AYURVEDA ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹124 Cr |
| Mar2024 | ₹141 Cr |
| Mar2023 | ₹115 Cr |
| Mar2022 | ₹110 Cr |
| Mar2021 | ₹114 Cr |
How is Total Liabilities of KERALA AYURVEDA Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹124 Cr | -11.88 | |
| Mar2024 | ₹141 Cr | 22.14 | |
| Mar2023 | ₹115 Cr | 4.68 | |
| Mar2022 | ₹110 Cr | -3.36 | |
| Mar2021 | ₹114 Cr | - | |
Compare Total Liabilities of peers of KERALA AYURVEDA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KERALA AYURVEDA | ₹252.4 Cr | -8.1% | -12.1% | -49.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹432,096.0 Cr | -2.4% | 3% | 9.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹176,807.0 Cr | -3.3% | 3.5% | 4.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹148,718.0 Cr | -2% | 5% | 43.1% | Stock Analytics | |
| CIPLA | ₹112,971.0 Cr | -0% | 6.9% | -4.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,752.0 Cr | -0.3% | -3.8% | 7.3% | Stock Analytics | |
KERALA AYURVEDA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KERALA AYURVEDA | -8.1% |
-12.1% |
-49.1% |
| SENSEX | -0.5% |
-3.3% |
-7.6% |
You may also like the below Video Courses